BCPC 📈 Balchem - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0576652004
BCPC: Nutrition, Food, Pharmaceuticals, Animal Feed, Sterilization, Crop Protection
Balchem Corporation is a global developer, manufacturer, and marketer of specialty performance ingredients and products, catering to a diverse range of industries including nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial markets. The company's operations are structured into three distinct segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, each addressing specific needs and applications. The Human Nutrition & Health segment, for instance, supplies a variety of ingredients to the food and beverage industry, including spray-dried and emulsified powders, extrusion and agglomeration products, and blended lipid systems, among others. These products are designed to enhance the nutritional value, taste, and texture of food products, making them essential components in the production of ice cream, chocolate, cereals, and other consumer goods.
The Animal Nutrition & Health segment focuses on providing innovative solutions to enhance the health and productivity of animals, particularly in the livestock industry. This includes microencapsulated products that promote better nutrient absorption and utilization, leading to improved health outcomes and increased milk production in ruminant animals. Additionally, the company offers chelation technology, which facilitates enhanced nutrient absorption in various species of production and companion animals, as well as methylsulfonylmethane and choline chloride, both of which play critical roles in maintaining animal health. By offering these specialized products, Balchem contributes to the efficiency and sustainability of animal agriculture, helping to meet the global demand for high-quality protein sources.
The Specialty Products segment of Balchem Corporation is involved in the distribution of ethylene oxide and ammonia, primarily for use in the healthcare industry for sterilizing medical devices and equipment. This segment also markets single-use canisters designed for the sterilization of reusable devices, ensuring the highest standards of hygiene and safety in medical settings. Furthermore, Balchem sells propylene oxide, a versatile fumigant used to control insects and prevent microbiological spoilage in a variety of food products, including nuts, spices, cacao beans, and dried fruits. The company's product portfolio in this segment is rounded out by chelated minerals, which are used in high-value crops to enhance growth, yield, and nutritional content, reflecting Balchem's commitment to supporting sustainable agricultural practices.
Balchem Corporation's business model is built around a combination of direct sales through its in-house sales force and indirect sales via independent distributors and sales agents. This multi-channel approach enables the company to effectively reach and serve its diverse customer base across different geographic regions and industries. With a history dating back to 1967, Balchem is headquartered in Montvale, New Jersey, and has established itself as a reputable player in the specialty chemicals sector, with its common stock listed on the NASDAQ under the ticker symbol BCPC. The company's web presence can be found at https://www.balchem.com, providing access to detailed information about its products, services, and corporate activities.
Additional Sources for BCPC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BCPC Stock Overview
Market Cap in USD | 5,771m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1986-06-03 |
BCPC Stock Ratings
Growth 5y | 59.0% |
Fundamental | 60.3% |
Dividend | 48.6% |
Rel. Strength Industry | 456 |
Analysts | 4/5 |
Fair Price Momentum | 165.73 USD |
Fair Price DCF | 129.39 USD |
BCPC Dividends
Dividend Yield 12m | 0.72% |
Yield on Cost 5y | 1.20% |
Annual Growth 5y | 17.97% |
Payout Consistency | 96.9% |
BCPC Growth Ratios
Growth Correlation 3m | 37.3% |
Growth Correlation 12m | 85.2% |
Growth Correlation 5y | 74.4% |
CAGR 5y | 10.78% |
CAGR/Mean DD 5y | 0.77 |
Sharpe Ratio 12m | 0.48 |
Alpha | -4.96 |
Beta | 0.66 |
Volatility | 25.12% |
Current Volume | 571.2k |
Average Volume 20d | 148.4k |
As of December 21, 2024, the stock is trading at USD 165.49 with a total of 571,223 shares traded.
Over the past week, the price has changed by -5.83%, over one month by -7.04%, over three months by -5.29% and over the past year by +16.53%.
Yes, based on ValueRay Fundamental Analyses, Balchem (NASDAQ:BCPC) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 60.31 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCPC as of December 2024 is 165.73. This means that BCPC is currently overvalued and has a potential downside of 0.15%.
Balchem has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BCPC.
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BCPC Balchem will be worth about 181.9 in December 2025. The stock is currently trading at 165.49. This means that the stock has a potential upside of +9.94%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 190.3 | 15% |
Analysts Target Price | 157 | -5.1% |
ValueRay Target Price | 181.9 | 9.9% |